Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert
Tech and Science

Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert

Last updated: July 5, 2025 2:30 am
Share
Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds : ScienceAlert
SHARE

GLP-1 Agonists Show Promise in Alleviating Migraines, Study Suggests

Medications like Ozempic, Wegovy, and Saxenda, originally designed to treat type 2 diabetes, have gained popularity for their weight-loss benefits. However, recent research indicates that these GLP-1 agonists may have additional health benefits beyond weight management.

A pilot trial conducted by researchers at the University of Naples in Italy explored the potential of the GLP-1 agonist liraglutide in reducing migraine frequency and intensity in patients with obesity. The study involved 31 participants with high BMI and frequent or chronic migraines who received daily injections of liraglutide.

The results were promising, with participants experiencing a significant decrease in the number of migraine days per month after 12 weeks of treatment. The mean number of migraine days decreased from 19.8 days to just 10.7 days, indicating a nearly 50% reduction in migraine frequency.

Importantly, the migraine relief observed in the study was independent of factors such as weight loss, age, sex, and concurrent medication use, suggesting that liraglutide may have a direct impact on migraine management.

While further research with larger cohorts and control groups is needed to confirm these findings, the study highlights the potential of GLP-1 agonists like liraglutide as a promising avenue for future migraine treatments.

Understanding the Mechanisms of Action

GLP-1 agonists work by mimicking a natural hormone in the body called glucagon-like peptide-1, which helps regulate blood sugar levels and appetite. These medications have widespread effects throughout the body due to the presence of GLP-1 receptors in various tissues and organs.

Past studies have suggested that GLP-1 agonists may reduce intracranial pressure in the brain, a potential trigger for migraines. Animal models have also shown the effectiveness of these drugs in suppressing migraines.

See also  World's Oldest Arrow Poison Found in Ancient Bone From 7,000 Years Ago : ScienceAlert

While the exact mechanisms behind liraglutide’s migraine-relieving effects are still being elucidated, researchers believe that the reduction in intracranial pressure may play a role in alleviating migraines. Recent animal studies have demonstrated that GLP-1 agonists can reduce fluid in the central nervous system, thereby lowering intracranial pressure.

Potential Implications for Migraine Management

Migraines affect a significant portion of the global population, yet current treatment options do not work for everyone. For individuals with migraines that are unresponsive to conventional therapies, GLP-1 agonists like liraglutide could offer a novel approach to migraine management.

The findings of this pilot trial provide a foundation for larger-scale studies to further investigate the role of GLP-1 agonists in migraine treatment. By targeting mechanisms beyond weight loss and metabolic effects, these medications may offer new hope for migraine sufferers.

The study was published in the journal Headache and underscores the potential of GLP-1 agonists in expanding the therapeutic options for migraine patients.

TAGGED:ChronicDrugsfindsMigrainesOzempicLikeScienceAlerttreatTrial
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Nòstos (Homecoming)’ by Andrea Agostini ‘Nòstos (Homecoming)’ by Andrea Agostini
Next Article Jim Cramer Says “Meta is a Ridiculously Cheap Stock” Jim Cramer Says “Meta is a Ridiculously Cheap Stock”
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Man Who Accidentally Threw Hard Drive Containing 8,000 Bitcoins Worth Half A Billion Dollars In Landfill Sues Local City Council For Not Excavating The Site

James Howells, a Wales-based software engineer, made headlines after accidentally discarding a hard drive containing…

October 14, 2024

You can make fair dice from any shape you like

All Shapes Can Now Be Transformed into Fair Dice for Gaming All of these strange-looking…

May 28, 2025

Keira Knightley Is Loving Her Thriller Era

Keira Knightley has taken a thrilling turn in her acting career, immersing herself in high-stakes…

October 1, 2025

Spoiled by success – Econlib

Human beings possess an undeniable restlessness. Even at the height of achievement, we find ourselves…

May 3, 2025

DeepSeek AI cranks open the spigots on Chinese venture capital

China's venture capital world is buzzing with excitement after DeepSeek's recent artificial intelligence breakthrough. This…

March 12, 2025

You Might Also Like

Conservative group finds teachers are celebrating Charlie Kirk’s death
World News

Conservative group finds teachers are celebrating Charlie Kirk’s death

October 10, 2025
Worlds Apart Crossword
Tech and Science

Worlds Apart Crossword

October 10, 2025
Lasers made muon beams, no massive accelerator needed
Tech and Science

Lasers made muon beams, no massive accelerator needed

October 10, 2025
Brain scans reveal where taste and smell become flavor
Tech and Science

Brain scans reveal where taste and smell become flavor

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?